Month: March 2023

FDA Approves Skyclarys (omaveloxolone) for the Treatment of Friedreich’s Ataxia PLANO, Texas–(BUSINESS WIRE) February 28, 2023 — Reata Pharmaceuticals, Inc. (Nasdaq: RETA) (“Reata,” the “Company,” “our,” “us,” or “we”), a biopharmaceutical company focused on developing and commercializing novel therapies for patients with severe diseases, announced that the U.S. Food and Drug Administration (“FDA”) has approved
0 Comments
“The word cerebellum means “little brain”. It is a structure of the nervous system that has an important role in motor control. In particular, the cerebellum is important in the coordination, precision, and timing of movements, as well as motor learning and the maintenance of muscle tone, balance and posture.” Join this channel to get
0 Comments
Muscle relaxants and nonsteroidal anti-inflammatory drugs (NSAIDs) effectively improved symptoms of acute low back pain after 1 week of treatment, based on data from more than 3000 individuals. Acute low back pain (LBP) remains a common cause of disability worldwide, with a high socioeconomic burden, write Alice Baroncini, MD, of RWTH University Hospital, Aachen, Germany,
0 Comments
The act of self-harm is a sign we need support, but how can we recognise this and ask for help? Despite how far we’ve come in many aspects of mental health acceptance and understanding, self-harm still feels like one of those topics seeped in stigma and misunderstanding. While I’m open about a lot of my
0 Comments
Should You Call Someone ‘Diabetic’? – Diabetes Daily Learning Center Learning Center: LearningCenter Diabetes Daily does not provide medical advice,diagnosis or treatment.Get additional information.© 2005 – 2023 Everyday Health, Inc., a Ziff Davis company. Everyday Health is among the federally registered trademarks of Everyday Health, Inc. and may not be used by third parties without
0 Comments
JUPITER, Fla. and BOSTON, Feb. 27, 2023. Jupiter Neurosciences, Inc. (“Jupiter” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline focused on the treatment of central nervous system (CNS) disorders and rare diseases, today announced topline proof-of-concept preclinical data with its proprietary resveratrol drug product, JOTROL, for Parkinson’s Disease (PD). In collaboration with scientists
0 Comments
New research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) is the first study to show that childhood obesity is associated with an increased risk of four of the five recently proposed subtypes of adult-onset diabetes. The study is by Yuxia Wei, Institute of Environmental Medicine, Karolinska Institutet,
0 Comments
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images The Food and Drug Administration’s independent advisors on Tuesday recommended what would be the world’s first RSV vaccine, a shot from Pfizer for adults ages 60 and older, despite safety concerns after two trial participants developed a rare neurological disorder.  A
0 Comments
SAN ANTONIO — Epicutaneous immunotherapy (EPIT) administered through an investigational skin patch over 12 months led to more responses — with favorable safety — compared with placebo in peanut-allergic toddlers with and without other food allergies or atopic dermatitis (AD), according to two subanalyses of the phase III EPITOPE trial. Among children ages 1 to
0 Comments
“I just can’t. I can’t,” Wendy, an RN, sobbed into my hair. We barely made it out the door when our bodies collapsed together, puddles holding puddles. Our patient’s children, 5 and 7, had just left with their tiny gray backpacks, tiny soldiers off to the abyss. Pastel crayon drawings, with rainbows and stick figures,
0 Comments
This blog shares some ways to tell if a new or existing lump could be a sarcoma and, if so, what steps you should take next. If you are not sure, see your primary care provider. What is Sarcoma? A sarcoma is a type of cancer that forms in bone or soft tissues like muscle, nerves, fat,
0 Comments
Treatment for Presbyopia FDA Accepts Orasis Pharmaceuticals’ New Drug Application for CSF-1 for the Treatment of Presbyopia Investigational, novel eye drop candidate was assigned PDUFA goal date of October 22, 2023 Ponte Vedra, FL, February 21, 2023 – Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to improve near
0 Comments
THOUSAND OAKS, Calif., Feb. 2, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved Tezspire® (tezepelumab-ekko) for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.1 First approved by the FDA in December 2021, Tezspire is the only biologic
0 Comments
Breast cancer cells might use bioelectric signals to influence their behaviour. NIH / CC BY-NC 2.0 You’re electric. Not in a charge-via-USB, keep-away-from-water kind of way – but electric all the same. We all are. Electricity is a big part of how our bodies work. Our cells need to keep certain chemicals inside and push
0 Comments